Expedition 74 crew return this weekend ends eight months of ISS research into cancer drug delivery nanoparticles and ...

Researchers at the University at Albany's RNA Institute revealed the award ahead of World RNA Day on Wednesday.

For more than a century, scientists have sought to reconstruct human evolution using diverse lines of evidence, including fossils, genetic variation across populations, and ancient DNA.

Organometallic complexes represent an important class of compounds with high potential as anticancer agents in modern ...

In a small study, restricting calories led to greater weight loss among people with a biological age younger than their ...

While immune checkpoint inhibitors and other immunotherapies have revolutionised oncology, therapeutic responses remain highly variable. Most of these ...

The firm looks to position its Halo lung assay for detecting cancers not found by LDCT and in average-risk populations for which LDCT screening is not currently recommended.

Common encouragements can inadvertently erase the incurable biology of metastatic breast cancer and shift conversations away from prognosis, uncertainty, and ongoing treatment burden. Avoidance of ...

Another child with a highly aggressive tumor has so far survived for two years after receiving the experimental treatment.

Justin Balko, PharmD, PhD, explains why residual disease in triple-negative breast cancer signals a biology gap, and what ADC trials and cell-free DNA monitoring may reveal. Patients with stage 2 and ...

Enhancers are pieces of DNA that act like switches, regulating when genes are turned on and off and how strongly they are activated.

In an interview, Carl H. June discusses how CAR-T therapy transformed blood cancer treatment, the challenges of extending it ...